Literature DB >> 33534739

Specificity of the Point-of-Care Urine Strip Test for Schistosoma Circulating Cathodic Antigen (POC-CCA) Tested in Non-Endemic Pregnant Women and Young Children.

Miriam Casacuberta-Partal1, Margreet Beenakker1, Claudia J de Dood2, Pytsje T Hoekstra1, Lisa Kroon1, Dieuwke Kornelis1, Paul Corstjens2, Cornelis H Hokke1, Govert J van Dam1, Meta Roestenberg1,3, Lisette van Lieshout1.   

Abstract

The point-of-care urine based strip test for the detection of circulating cathodic antigen (POC-CCA) in schistosome infections is a frequently used tool for diagnosis and mapping of Schistosoma mansoni in school-aged children. Because of its ease of use, the test is increasingly applied to adults and preschool-aged children (PSAC), but its performance has not been specifically evaluated in these target groups. Recent observations have raised concerns about possible reduced specificity, in particular in pregnant women (PW) and PSAC. We thus explored specificity of the POC-CCA urine strip test (Rapid Medical Diagnostics, Pretoria, South Africa) in a non-endemic, nonexposed population of 47 healthy nonpregnant adults (NPAs), 52 PW, and 58 PSAC. A total of 157 urines were tested with POC-CCA, of which five (10.6%) NPAs, 17 (32.7%) PW, and 27 (46.5%) PSAC were positive. The highest scores were found in the youngest babies, with an infant of 9 months being the oldest positive case. On measuring pH, it appeared that all POC-CCA strongly positive urines were acidic (pH range 5-5.5), whereas addition of pH-neutral buffer to a subsample reversed the false positivity. We conclude that the POC-CCA test has reduced specificity in PW and infants younger than 9 months, but that the false positivity might be eliminated by modifications in the buffers used in the test.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33534739      PMCID: PMC8045634          DOI: 10.4269/ajtmh.20-1168

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  3 in total

1.  Performance of a rapid immuno-chromatographic test (Schistosoma ICT IgG-IgM) for detecting Schistosoma-specific antibodies in sera of endemic and non-endemic populations.

Authors:  Julie Hoermann; Esther Kuenzli; Carmen Schaefer; Daniel H Paris; Silja Bühler; Peter Odermatt; Somphou Sayasone; Andreas Neumayr; Beatrice Nickel
Journal:  PLoS Negl Trop Dis       Date:  2022-05-27

2.  Translating From Egg- to Antigen-Based Indicators for Schistosoma mansoni Elimination Targets: A Bayesian Latent Class Analysis Study.

Authors:  Jessica Clark; Arinaitwe Moses; Andrina Nankasi; Christina L Faust; Moses Adriko; Diana Ajambo; Fred Besigye; Arron Atuhaire; Aidah Wamboko; Candia Rowel; Lauren V Carruthers; Rachel Francoeur; Edridah M Tukahebwa; Poppy H L Lamberton; Joaquin M Prada
Journal:  Front Trop Dis       Date:  2022-02-18

3.  Sensitive Diagnosis and Post-Treatment Follow-Up of Schistosoma mansoni Infections in Asymptomatic Eritrean Refugees by Circulating Anodic Antigen Detection and Polymerase Chain Reaction.

Authors:  Pytsje T Hoekstra; Afona Chernet; Claudia J de Dood; Eric A T Brienen; Paul L A M Corstjens; Niklaus D Labhardt; Beatrice Nickel; Linda Wammes; Govert J van Dam; Andreas Neumayr; Lisette van Lieshout
Journal:  Am J Trop Med Hyg       Date:  2022-02-28       Impact factor: 2.345

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.